NCT01605942View on ClinicalTrials.gov

A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Cataract
Interventions
DRUG

Dexamethasone Drug Delivery System

Dexamethasone Drug Delivery System administered into the study eye at the conclusion of cataract surgery on Day 1.

DRUG

Placebo Drug Delivery System

Placebo Drug Delivery System administered into the study eye at the conclusion of cataract surgery on Day 1.

Trial Locations (1)

Unknown

Newport Beach

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01605942 - A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery | Biotech Hunter | Biotech Hunter